By Sabela Ojea
ViewRay Inc. on Wednesday withdrew its guidance for 2023 after posting wider losses in the first quarter of the year.
The radiation-therapy-system maker, which less than a month ago cut its full-year estimates, said it no longer expects revenue to be flat or to grow by up to 15% this year due to current market conditions.
Also Wednesday, ViewRay posted a net loss of $28.9 million, or 16 cents a share, compared with a loss of $25.8 million, or 14 cents a share, for the same period a year earlier.
Revenue rose 19%, to $22.5 million, missing analysts' expectations of $24.7 million.
Write to Sabela Ojea at sabela.ojea@wsj.com
(END) Dow Jones Newswires
May 10, 2023 18:38 ET (22:38 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.